Hepatitis D: all 63 studies
Page 1 of 1. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- EXPANDED-ACCESS PROGRAM FOR THE TREATMENT OF CHRONIC HEPATITIS D WITH BRELOVITUGAvailableNCT07922733
- Hepatitis B Infection SurveillanceNot yet recruitingNCT07727187
- A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)RecruitingNCT07499544Phase 3
- Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+DRecruitingNCT07491848
- "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.RecruitingNCT07317011
- A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)RecruitingNCT07200908Phase 3
- Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in FranceNot yet recruitingNCT07038863Not applicable
- HDV Screening StudyRecruitingNCT06889805
- Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)Not yet recruitingNCT06649396Not applicable
- MIGrant Reflex Test HDV (MIGRED) ProjectNot yet recruitingNCT06539052
- Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated CirrhosisRecruitingNCT06397859
- HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV CoinfectionRecruitingNCT06264583
- D-SOLVE Cohorts (Cohort A and B)RecruitingNCT06160635
- Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)RecruitingNCT06122285
- DELTA DESCRIBE: the French Collaborative ProjectRecruitingNCT05936073
- HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLVRecruitingNCT05928000
- Standardising Care for Hepatitis Delta in the NetherlandsRecruitingNCT05903742
- A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-InfectionNot yet recruitingNCT05467553Phase 2
- Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in ChinaNot yet recruitingNCT05451082
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".RecruitingNCT04690972
- Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
- Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonCompletedNCT03600714Phase 2Results posted
- A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DCompletedNCT03546621Phase 2Results posted
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedNCT02577029Phase 2Results posted
- Treatment of Chronic Delta Hepatitis With Lonafarnib and RitonavirCompletedNCT02511431Phase 2Results posted
- Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsCompletedNCT02344680Results posted
- Lonafarnib for Chronic Hepatitis DCompletedNCT01495585Phase 2Results posted
- Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)CompletedNCT00686790Phase 3Results posted
- Pegylated Interferon to Treat Chronic Hepatitis DCompletedNCT00023322Phase 2Results posted
- A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Active, not recruitingNCT07298330Phase 3
- A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionActive, not recruitingNCT07142811Phase 2
- A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideActive, not recruitingNCT07128550Phase 3
- A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionActive, not recruitingNCT06907290Phase 2/3
- A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionActive, not recruitingNCT06903338Phase 3
- Expanded Access for BulevirtideApproved for marketingNCT06780579
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy ParticipantsCompletedNCT06740474Phase 1
- A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis DCompletedNCT06505928Phase 2
- Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide TreatmentCompletedNCT06504485
- Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B VirusCompletedNCT06360484
- Patient Knowledge, Beliefs and Barriers to Hepatitis D CareStatus unknownNCT06017375
- Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in ItalyCompletedNCT05962307
- Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta HepatitisWithdrawnNCT05953545Phase 2
- A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus InfectionCompletedNCT05861674Phase 2
- Replicor Compassionate Access ProgramNo longer availableNCT05683548
- SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.Active, not recruitingNCT05461170Phase 2
- Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)Status unknownNCT05394623
- Disease Loads and Status of TreatmentStatus unknownNCT05264272
- Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus InfectionCompletedNCT05229991Phase 3
- Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVActive, not recruitingNCT05070364Phase 3
- Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT05002907
- Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Active, not recruitingNCT04863703
- A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus CoinfectionTerminatedNCT04847440Phase 2
- Epidemiological Survey of Hepatitis D Virus Infection in ChinaCompletedNCT04483518
- Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aCompletedNCT03719313Phase 3
- Epidemiology of Hepatitis B, C and Delta in Reunion IslandStatus unknownNCT03362866
- Chronic Hepatitis B Virus Infection in ZambiaCompletedNCT03158818
- Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis DStatus unknownNCT03105310Phase 2
- Ezetimibe for Patients With Chronic Hepatitis DStatus unknownNCT03099278Phase 2
- The Hepatitis Delta International NetworkCompletedNCT02375906
- Mother-to-child Hepatitis D TransmissionCompletedNCT02044055
- Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)TerminatedNCT01316185Phase 1
- HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta HepatitisCompletedNCT00932971Phase 2
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2